WHO supports wider use of weight-loss drugs, calling obesity a chronic disease
The guidelines focus on GLP-1 therapies – drugs such as liraglutide, semaglutide and tirzepatide – and offer conditional recommendations on how they can be used safely as part of long-term treatment. Living with obesity More than a billion people worldwide live with obesity, responsible for 3.7 million deaths in 2024. Without stronger action, WHO warns […]
